InsiderClue
Stocks · Health care · Pharmaceutical Preparations

IDEAYA Biosciences, Inc.

IDYA Clue Score67
United States Fiscal year ends December CIK 0001676725
$36.11 +0.14% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $36.11 +39.74% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 May 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−14.4Net income−11.9Fiscal year 2018Operating income−36.4Net income−34.3Fiscal year 2019Revenue0.0Operating income−44.3Net income−42.0Fiscal year 2020Revenue19.5Operating income−35.3Net income−34.5EPS, diluted−1.40Fiscal year 2021Revenue27.9 +43.0%Operating income−50.3Net income−49.8EPS, diluted−1.41Fiscal year 2022Revenue50.9 +82.3%Operating income−62.5Net income−58.7EPS, diluted−1.42Fiscal year 2023Revenue23.4 −54.1%Operating income−134.4Net income−113.0EPS, diluted−1.96Fiscal year 2024Revenue7.0 −70.1%Operating income−327.0Net income−274.5EPS, diluted−3.36Fiscal year 2025Revenue218.7 +3,024.4%Operating income−159.3Net income−113.7EPS, diluted−1.28
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 19.5 27.9 50.9 23.4 7.0 218.7
Growth +43.0% +82.3% −54.1% −70.1% +3,024.4%
Operating income −14.4 −36.4 −44.3 −35.3 −50.3 −62.5 −134.4 −327.0 −159.3
Net income −11.9 −34.3 −42.0 −34.5 −49.8 −58.7 −113.0 −274.5 −113.7
Growth
EPS, diluted n/a n/a n/a −1.40 −1.41 −1.42 −1.96 −3.36 −1.28
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Operating margin−180.9%Net margin−176.6%Free cash flow margin281.3%Fiscal year 2021Operating margin−179.9%Net margin−178.1%Free cash flow margin−209.1%Fiscal year 2022Operating margin−122.7%Net margin−115.2%Free cash flow margin−177.9%Fiscal year 2023Operating margin−574.9%Net margin−483.0%Free cash flow margin−502.9%Fiscal year 2024Operating margin−4,671.1%Net margin−3,921.1%Free cash flow margin−3,592.0%Fiscal year 2025Operating margin−72.8%Net margin−52.0%Free cash flow margin−33.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a −180.9% −179.9% −122.7% −574.9% −4,671.1% −72.8%
Net margin n/a n/a n/a −176.6% −178.1% −115.2% −483.0% −3,921.1% −52.0%
Free cash flow margin n/a n/a n/a 281.3% −209.1% −177.9% −502.9% −3,592.0% −33.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−12.2Capital expenditure−1.8Free cash flow−14.0Fiscal year 2018Operating cash flow−27.6Capital expenditure−1.7Free cash flow−29.3Fiscal year 2019Operating cash flow−39.3Capital expenditure−1.4Free cash flow−40.7Fiscal year 2020Operating cash flow55.5Capital expenditure−0.5Free cash flow55.0Fiscal year 2021Operating cash flow−55.8Capital expenditure−2.6Free cash flow−58.4 −206.3%Fiscal year 2022Operating cash flow−87.2Capital expenditure−3.4Free cash flow−90.6Fiscal year 2023Operating cash flow−115.2Capital expenditure−2.4Free cash flow−117.6Fiscal year 2024Operating cash flow−247.6Capital expenditure−3.9Free cash flow−251.4Fiscal year 2025Operating cash flow−71.1Capital expenditure−2.4Free cash flow−73.5
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −12.2 −27.6 −39.3 55.5 −55.8 −87.2 −115.2 −247.6 −71.1
Capital expenditure −1.8 −1.7 −1.4 −0.5 −2.6 −3.4 −2.4 −3.9 −2.4
Free cash flow −14.0 −29.3 −40.7 55.0 −58.4 −90.6 −117.6 −251.4 −73.5
Growth −206.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash6.0Shareholders’ equity−15.7Fiscal year 2018Cash20.5Shareholders’ equity−48.9Fiscal year 2019Cash34.1Shareholders’ equity100.4Fiscal year 2020Cash72.0Shareholders’ equity198.3Fiscal year 2021Cash92.0Shareholders’ equity301.5Fiscal year 2022Cash68.6Shareholders’ equity349.5Fiscal year 2023Cash157.0Shareholders’ equity621.1Fiscal year 2024Cash84.4Shareholders’ equity1,059.1Fiscal year 2025Cash112.8Shareholders’ equity1,022.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 6.0 20.5 34.1 72.0 92.0 68.6 157.0 84.4 112.8
Shareholders’ equity −15.7 −48.9 100.4 198.3 301.5 349.5 621.1 1,059.1 1,022.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−12.2 −27.6 −39.3 55.5 −55.8 −87.2 −115.2 −247.6 −71.1
Growth −200.6%
0.4 0.9 1.2 1.4 1.7 2.1 2.5 2.4 2.7
Investment
−1.8 −1.7 −1.4 −0.5 −2.6 −3.4 −2.4 −3.9 −2.4
calc −14.0 −29.3 −40.7 55.0 −58.4 −90.6 −117.6 −251.4 −73.5
Growth −206.3%
calc n/a n/a n/a 2.22 −1.66 −2.19 −2.04 −3.08 −0.83
−8.9 −63.2 2.3 −146.2 −69.7 −33.4 −158.5 −502.6 70.0
Financing
17.5 105.4 50.6 128.8 145.5 97.2 362.7 677.6 29.8

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.